Koppers vs Ingevity
KOP and NGVT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KOP and NGVT compare
Ingevity is the larger company, worth 3.6 times as much as Koppers ($2.1B against $589M).
Koppers grew revenue faster over the last twelve months (−0.85% versus −3.7% for Ingevity).
Ingevity keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −5.0% at Koppers.
Koppers pays a dividend yielding 1.1%; Ingevity does not pay one.
Koppers scores higher on the StockData Score (9 against 6 for Ingevity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KOP | NGVT |
|---|---|---|
| Size and price | ||
| Market cap | $589M | $2.1B |
| Share price | $31.16 | $61.72 |
| Change, 1 year | 9.1% | 25.6% |
| Change, 5 years | −3.6% | −21.7% |
| Beta (5Y) | 1.07 | 1.21 |
| Employees | 971 | 1,500 |
| StockData Score | ||
| Total score | 9 (better) | 6 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 2 (better) | 1 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | – | 36.3× |
| P/S | 0.3× (better) | 1.9× |
| P/B | 1.5× (better) | 33.7× |
| EV/EBITDA | 123× | 23.1× (better) |
| P/FCF | 4.9× (better) | 17.3× |
| FCF yield | 20.4% (better) | 5.8% |
| Fair value | $57.44 | $35.71 |
| Margin of safety | 45.8% (better) | −72.8% |
| Growth | ||
| Revenue growth (TTM) | −0.85% (better) | −3.7% |
| Revenue growth, 5Y average | 2.4% (better) | −0.81% |
| Net income growth (TTM) | −696% | – |
| EPS growth (TTM) | −736% | – |
| EPS growth, 5Y average | −13.7% | – |
| Profitability | ||
| Gross margin | 21.3% | 42.0% (better) |
| Operating margin | −3.3% | – |
| Net margin | −5.0% | 5.3% (better) |
| FCF margin | 6.3% | 10.8% (better) |
| Return on equity | −20.3% | 59.5% (better) |
| Return on invested capital | −3.8% | – |
| Financial health | ||
| Debt / equity | 2.21 (better) | 18.18 |
| Net debt / EBITDA | 72.26 | 7.68 (better) |
| Interest coverage | −1.1× | – |
| Current ratio | 2.37 (better) | 1.48 |
| Altman Z-score | 1.86 | 2.29 (better) |
| Piotroski F-score | 8 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | – |
| Years of dividend growth | 3 | – |
| Buyback yield | 9.1% (better) | 7.4% |
| Shareholder yield | 10.2% (better) | 7.4% |
| Ownership | ||
| Held by institutions | 103% | 102% |
| Held by insiders | 11.2% | 1.4% |
| Insider net buying, 12 months | −$5.6M | −$1.8M (better) |
| Short interest, % of float | 4.3% | 3.7% |
Go deeper
- KOP stock overview
- KOP income statement
- KOP valuation and score
- NGVT stock overview
- NGVT income statement
- NGVT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.